Contact us
Pharmaceutical companies or investors interested in learning more and partnering with OncoZenge to bring BupiZenge™ to market, get in touch:
Get in touch
General
For general inquiries contact us at info@oncozenge.se
Media
For media or investor queries please contact our CEO Stian Kildal
Mailing address
Gustavslundsvägen 34, 167 51 Stockholm, Sweden
Subscribe to our newsletter!
Sign up today and receive company updates straight to your inbox.